Multiplex PCR Assays Market

Multiplex PCR Assays Market Outlook (2023 to 2033)

The multiplex PCR assays market size is projected to be worth USD 1.3 billion in 2023. The market is likely to surpass USD 3.0 billion by 2033 at a CAGR of 8.5% during the forecast period.

The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections, and gastrointestinal infections, continues to rise. Multiplex PCR assays play a crucial role in the diagnosis and surveillance of these diseases by enabling the simultaneous detection of multiple pathogens. The increasing prevalence of infectious diseases is expected to drive the demand for multiplex PCR assays.

Other Drivers Propelling the Demand for Multiplex PCR Assays Market include:

• Multiplex PCR assays are widely used in research laboratories for various applications, including gene expression analysis, genotyping, and mutation detection. The increasing adoption of molecular techniques in research settings is driving the demand for multiplex PCR assays.
• Both academic and industrial research institutions are actively engaged in the development of multiplex PCR assays for various applications. The focus is on expanding the range of detectable targets, improving assay performance, and exploring new applications in areas such as oncology, genetic testing, and personalized medicine. The ongoing research and development efforts are expected to fuel market growth.
• Multiplex PCR assays have gained significant importance in the field of molecular diagnostics. The increasing demand for efficient and reliable diagnostic techniques is driving the growth of the market.

Challenges for Companies /Manufacturers in the Multiplex PCR Assays Market:

• Regulatory approval processes for diagnostic assays can be time-consuming and complex. Multiplex PCR assays must meet stringent regulatory requirements to ensure accuracy, reliability, and safety. Compliance with regulations such as the USA FDA approval or the European CE mark certification can pose challenges and delay market entry for new assays.
• Multiplex PCR assays face competition from alternative diagnostic technologies, such as next-generation sequencing (NGS), microarrays, and digital PCR. The growing adoption of these alternative technologies poses a challenge for the market share of multiplex PCR assays.
• The awareness and adoption of multiplex PCR assays can vary across different regions and healthcare settings. In some areas, particularly in developing regions, there may be limited awareness about the benefits and applications of multiplex PCR assays. This can significantly obstruct the growth of the market.

Opportunities in the Multiplex PCR Assays Industry:

• The field of multiplex PCR assays is witnessing continuous technological advancements. These advancements include the development of new multiplex PCR platforms, improved primer design strategies, and enhanced detection methods. These innovations are leading to improved sensitivity, specificity, and multiplexing capacity of the assays, thereby expanding their applications and driving market growth.
• The need for efficient and reliable diagnostic tools is growing rapidly. Multiplex PCR assays offer the ability to simultaneously detect multiple targets in a single reaction, providing faster results and reducing the need for multiple individual tests.
• Automation plays a crucial role in streamlining laboratory workflows and increasing efficiency. Integrating multiplex PCR assays with automated platforms and high-throughput systems allows for higher sample throughput and reduces manual handling, leading to increased productivity and cost savings.

Latest Trends in the Multiplex PCR Assays Market:

• The demand for customized multiplex PCR assay panels is increasing. Instead of relying solely on commercially available multiplex panels, researchers and clinicians are opting for customizable assays tailored to their specific needs. This trend enables the detection of a combination of targets relevant to a particular disease.
• While infectious disease testing has been a primary application of multiplex PCR assays, there is a growing trend of exploring their use in non-infectious disease applications. Multiplex PCR assays are being employed in areas such as oncology, genetic testing, pharmacogenomics, and prenatal screening.
• The multiplex PCR assays market is experiencing significant growth in emerging markets, including Asia-Pacific, Latin America, and the Middle East. Factors such as improving healthcare infrastructure, rising awareness about advanced diagnostic technologies, and increasing healthcare expenditure are driving the adoption of multiplex PCR assays in these regions.

Attributes	Details
Multiplex PCR Assays Market Size (2023)	USD 1.3 billion
Multiplex PCR Assays Market Projected Size (2033)	USD 3.0 billion
Value CAGR (2023 to 2033)	8.5%

2017 to 2022 Multiplex PCR Assays Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2017 to 2022, the global multiplex PCR assays market experienced a CAGR of 7.8%, reaching a market size of USD 1.3 billion in 2023.

Multiplex PCR assays play a vital role in diagnostic applications, particularly in infectious disease testing. The need for rapid and accurate detection of multiple pathogens in a single test is driving the demand for multiplex PCR assays.

With the increasing prevalence of infectious diseases, such as respiratory infections, sexually transmitted infections, and hospital-acquired infections, the demand for multiplex PCR assays is expected to grow.

Future Forecast for Multiplex PCR Assays Industry:

Looking ahead, the global multiplex PCR assays market is expected to rise at a CAGR of 8.5% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 3.0 billion by 2033.

Point-of-care (POC) and decentralized testing are gaining prominence in healthcare. Multiplex PCR assays offer the potential for on-site, rapid, and accurate diagnosis in settings such as clinics, emergency departments, and resource-limited areas. The demand for multiplex PCR assays in POC and decentralized testing is expected to increase as the focus on accessible and timely diagnostics grows.

Country-Wise Insights

What is Spurring the Growth of the USA Market?

Country	The United States
Market Size (USD Million) by End of Forecast Period (2033)	USD 740.9 million
CAGR % 2023 to End of Forecast (2033)	7.1%

The multiplex PCR assays market in the United States is expected to reach a market size of USD 740.9 billion by 2033, expanding at a CAGR of 7.1%.

The USA has a substantial burden of infectious diseases, including respiratory infections, sexually transmitted infections, and healthcare-associated infections. The increasing demand for accurate and comprehensive infectious disease testing is driving the growth of the multiplex PCR assays market in the USA

• The USA is at the forefront of genomics research and molecular diagnostics. The continuous advancements in sequencing technologies, genetic understanding, and biomarker discovery are driving the demand for multiplex PCR assays

Multiplex PCR Assays Market is Expected to Grow at a Significant Rate Owing to Strong Research and Development Landscape.

Country	The United Kingdom
Market Size (USD Million) by End of Forecast Period (2033)	USD 146.9 million
CAGR % 2023 to End of Forecast (2033)	8.7%

The multiplex PCR assays market in the United Kingdom is expected to reach a market value of USD 146.9 billion, expanding at a CAGR of 8.7% during the forecast period. The UK has a strong research and development landscape, with renowned academic institutions, biotechnology companies, and pharmaceutical companies actively engaged in life sciences research.

Multiplex PCR assays are widely utilized in research laboratories for their ability to detect multiple targets simultaneously. The expanding research and development activities across diverse fields, such as genomics, oncology, and infectious diseases, are driving the demand for multiplex PCR assays in the UK.

Why China is a Lucrative Market in East Asia Multiplex PCR Assays Market?

Country	China
Market Size (USD billion) by End of Forecast Period (2033)	USD 188.7 billion
CAGR % 2023 to End of Forecast (2033)	6.6%

The multiplex PCR assays market in China is anticipated to reach a market size of USD 188.7 billion by the end of 2033, growing at a CAGR of 6.6% throughout the forecast period. China has faced several epidemics and disease outbreaks in the past, which has heightened the focus on epidemic and disease control measures.

Multiplex PCR assays play a critical role in rapid and accurate diagnosis, surveillance, and control of infectious diseases. The emphasis on epidemic and disease control drives the demand for multiplex PCR assays as essential tools in public health initiatives.

Substantial Investments in Healthcare Infrastructure and Technology Have Led Japan to Develop and Innovate Novel Multiplex PCR Assays.

Country	Japan
Market Size (USD billion) by End of Forecast Period (2033)	USD 115.0 billion
CAGR % 2023 to End of Forecast (2033)	7.0%

The multiplex PCR assays market in Japan is estimated to reach a market size of USD 115.0 billion by 2033, expected to thrive at a CAGR of 7.0%. Japan has made significant investments in healthcare infrastructure and technology, leading to advancements in diagnostics and molecular testing.

The country has witnessed improvements in laboratory facilities, research capabilities, and access to advanced diagnostic technologies. These developments create a favorable environment for the adoption of multiplex PCR assays in Japan.

Demand for Multiplex PCR Assays Market is Rising Due to Rapidly Expanding Biopharmaceutical and Pharmaceutical Industry.

Country	South Korea
Market Size (USD billion) by End of Forecast Period (2033)	USD 51.9 billion
CAGR % 2023 to End of Forecast (2033)	4.7%

The multiplex PCR assays market in South Korea is expected to reach a market size of USD 51.9 billion, expanding at a CAGR of 4.7% during the forecast period. South Korea’s biotechnology and pharmaceutical industries have been growing rapidly in recent years. The country has made significant investments in research and development, fostering innovation in life sciences. Multiplex PCR assays find applications in various research and clinical areas, making them valuable tools for biotech and pharma companies. The expansion of these industries fuels the demand for multiplex PCR assays in South Korea.

Category-Wise Insights

Which Segment of Product & Service Dominated the Global Market?

Instrument segment dominated the multiplex PCR assays market with a market share of 53.5% in 2022. Instruments typically have a longer lifespan compared to consumables. Once purchased, instruments can be used for several years with proper maintenance and calibration.

In contrast, consumables such as PCR reagents, primers, probes, and plates are required for each assay and need to be replenished regularly. The lower replacement frequency of instruments compared to consumables contributes to their dominance in the market.

Which Assay Type is Widely Utilized in the Multiplex PCR Assays Industry?

Based on assay type, planar assay segment has dominated the category withholding the significant share of the market at around 64.5% at the end of 2022. Planar assays offer the ability to simultaneously detect and analyze multiple targets in a single assay. They enable the parallel detection of multiple DNA or RNA sequences, gene mutations, or protein markers in a high-throughput manner.

This multiplexing capability is crucial for applications that require the simultaneous analysis of multiple targets, such as genotyping, mutation screening, gene expression profiling, and pathogen detection.

Which Segment is Expected to Lead the ‘Application’ Category Throughout the Forecast Period?

By application, research and development segment is expected to continue leading the market over a CAGR of 9.2% throughout the projected timeframe. Multiplex PCR assays simplify experimental workflows in research and development.

By consolidating multiple targets into a single assay, researchers can reduce the number of experimental steps, including DNA extraction, PCR setup, and sample handling. This streamlining of workflows minimizes the risk of errors, improves reproducibility, and enhances overall experimental efficiency.

Which End User Has Widely Adopted the Multiplex PCR Assay?

The biopharmaceutical companies have led the multiplex PCR assays market as the leading end user with the market share of 40.7% in 2022. Biopharmaceutical companies are engaged in the research and development of new drugs and therapies.

Multiplex PCR assays play a crucial role in the early stages of drug discovery by enabling the simultaneous analysis of multiple genes, biomarkers, or mutations associated with diseases or drug responses. These assays help in identifying potential drug targets, characterizing patient populations, and assessing the efficacy and safety of candidate drugs.

How Key Players Stay Competitive in the Multiplex PCR Assays Industry?

The multiplex PCR assays industry includes several key players that are actively involved in the development, manufacturing, and distribution of multiplex PCR assay products. Manufacturers are heavily investing in the research and developments activities to come up with novel products in the industry.

Key Strategies Used by the Participants

Product & Service Innovation

Key players continuously invest in research and development to introduce innovative products. They strive to develop assays with improved sensitivity, specificity, accuracy, and ease of use.

Strategic Partnerships and Collaborations

Key players often form strategic partnerships and collaborations with other companies, research institutions, and healthcare organizations. These partnerships can lead to knowledge sharing, joint product development, and expanded market reach.

Expansion into Emerging Markets

Expanding into emerging markets with growing healthcare infrastructure and rising demand for multiplex PCR assays allows companies to tap into new opportunities and gain a competitive edge.

Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to streamline their product portfolio, obtain new technologies, enter new market niches, and gain access to novel products or intellectual property.

Key Players in the Multiplex PCR Assays Industry

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• QIAGEN
• Luminex Corporation
• Fluidigm Corporation
• BioFire Diagnostics.

Key Developments in the Multiplex PCR Assays Market:

In June 2021, Bio-Rad confirmed its agreement with Seegene to supply molecular testing services in the USA market.

Segmentation Analysis of the Multiplex PCR Assays Market

By Product & Service:

• Consumables
• Instruments
• Software and Services

By Assay Type:

• Planar Assay
  • Blends Protein Arrays (Multiplexed ELISA)
  • Antibody Arrays
• Bead-based Assay
  • Magnetic Bead-based
  • Non-magnetic Bead-based

By Application:

• Disease Diagnosis
  • Infectious Disease
  • Cancer
  • Autoimmune Disease
  • Other Diseases
• Research and Development
• Other Application

By End User:

• Biopharmaceutical Companies
• Clinical Research Organizations
• Academic Research Institutes
• Diagnostic Centers
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Frequently Asked Questions

What is the Current Worth of the Multiplex PCR Assays Market?

The global multiplex PCR assays market is expected to reach a valuation of USD 1.3 billion by 2023.

How is the Demand for Multiplex PCR Assays Market Increasing?

The multiplex PCR assays market demand is set to expand by 8.5% during the assessment period.

Which Product & Service Holds the Notable Market Share in the Global Multiplex PCR Assays Market?

The instrument segment is projected to hold the dominant share of the market.

What is the Predicted Valuation of the Multiplex PCR Assays Market by 2033?

The market is predicted to exceed USD 3.0 billion by 2033.

Which is the Most Profitable Region for the Multiplex PCR Assays Industry?

The North America offers key opportunities for new entrants in the multiplex PCR assays market.